Dr. Mallory is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 Forest Glen Rd
Silver Spring, MD 20910
Education & Training
- Yale School of MedicineClass of 1997
Certifications & Licensure
- MD State Medical License 2002 - 2015
Clinical Trials
- A Phase II, Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine, CAIV-T in Healthy Children and Adolescents Ages 6 to Less Than 18 Years. Start of enrollment: 2003 Jun 01
- Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Live Cold-adapted (CAIV-T) in Healthy Children Start of enrollment: 2000 Oct 01
Publications & Presentations
PubMed
- 41 citationsEvaluation of MEDI8852, an Anti-Influenza A Monoclonal Antibody, in Treating Acute Uncomplicated InfluenzaS. Omar Ali, Therese Takas, Andrew C. Nyborg, Kathryn Shoemaker, Nicole L. Kallewaard
Antimicrobial Agents and Chemotherapy. 2018-10-24 - 25 citationsBenralizumab does not impair antibody response to seasonal influenza vaccination in adolescent and young adult patients with moderate to severe asthma: results from th...Pamela L. Zeitlin, Mila Leong, Jeremy Cole, Raburn M. Mallory, Vivian H. Shih
Journal of Asthma and Allergy. 2018-08-16 - 33 citationsShedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6-59 months of age.Raburn M. Mallory, Tingting Yi, Christopher S. Ambrose
Vaccine. 2011-06-10
Journal Articles
- A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of MEDI8852, an Anti-Influenza A Monoclonal Antibody, in Healthy Adult Volunteers☆Raburn M Mallory, Martin Kankam, ScienceDirect
Press Mentions
- Novavax Reports Third Quarter 2021 Financial Results and Operational HighlightsNovember 4th, 2021
- FluMist Vaccine Approved by CDC Without Proof It Works as AdvertisedOctober 3rd, 2018
- It’s OK to Use Nasal Spray Flu Vaccine Again, US Panel SaysFebruary 21st, 2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: